Clinical Trial Results: Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Balcinrenone/Dapagliflozin versus Dapagliflozin in adults with chronic kidney disease; results posted and study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Balcinrenone/Dapagliflozin
• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-06-26